Clinical Trial: To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07629583) titled 'To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis' on June 01.

Brief Summary: The study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cevostamab in participants with systemic lupus erythematosus (SLE) with or without active lupus nephritis (LN).

Study Start Date: July 31

Study Type: INTERVENTIONAL

Condition: Lupus Erythematosus, Systemic

Intervention: DRUG: Cevostamab

Participants will receive cevostamab IV as per the schedule given in the protocol.

DRUG: Tocilizumab

Tocilizumab may be used as rescue medication fo...